Kiniksa Pharmaceuticals, Ltd. (KNSA)
NASDAQ·Healthcare·Biotechnology
$51.99
+0.79%
Mkt Cap $3.88B
Analyst Ratings
Buy
9
Hold
0
Sell
0
Price Target (9 analysts)
$58.33
Range $55.00 – $62.00
Implied Upside
+12.2%
Consensus $58.33 vs current $51.99
NASDAQ·Healthcare·Biotechnology
$51.99
+0.79%
Mkt Cap $3.88B
Buy
9
Hold
0
Sell
0
Price Target (9 analysts)
$58.33
Range $55.00 – $62.00
+12.2%
Consensus $58.33 vs current $51.99